Skip to main content
GOV.UK

Blog MedRegs

Organisations:
Medicines and Healthcare products Regulatory Agency

Exploring AI in Healthcare: Insights from the AI Airlock Pilot

Exploring AI in Healthcare: Insights from the AI Airlock Pilot

The AI Airlock is a pilot programme designed to help test and improve the rules for AI-powered medical devices to ensure they reach patients quickly, safely and effectively. Since we announced the pilot cohort in early December, the AI Airlock …

Read more of Exploring AI in Healthcare: Insights from the AI Airlock Pilot

Help with Type 1B variations

Posted by: Julia Coombes, Posted on: 10 January 2017 - Categories: Variations

The Product Information Quality Unit (PIQU) team often gets asked for help during a Type 1B variation procedure. This ranges from providing advice on missing documents to explaining why the proposed changes are not acceptable first time around.

Read more of Help with Type 1B variations

Welcome to the MedRegs Blog

Posted by: Siu Ping Lam, Posted on: 9 January 2017 - Categories: From the Top
https://youtu.be/DBX5ZmOWbbQ

If you’re working to develop and submit applications to MHRA for marketing authorisations and clinical trial authorisations, then you need to keep up to date with the latest regulatory thinking and be able to easily find tips and tricks to avoid common pitfalls.

Read more of Welcome to the MedRegs Blog
Previous page
  • Page 1
  • …
  • Page 6
  • Page 7

Related content and links

MedRegs Blog

An official blog of the Medicines and Healthcare products Regulatory Agency (MHRA), providing expert insight on the latest regulatory thinking and all aspects of medicines regulation.

Find out more.

Categories

  • AI Airlock
  • antimicrobial resistance (AMR)
  • Behind the Scenes
  • Biological Medicines
  • Clinical Trials
  • Conferences and events
  • Diagnostics
  • eCTD
  • From the Top
  • Good Clinical Practice
  • Improving Our Services
  • Innovation
  • Med Tech Regulations
  • Medical Devices
  • Medicines in pregnancy
  • Medicines Packaging
  • Model informed Drug development (MIDD)
  • Patient involvement
  • Post-Market Surveillance
  • Uncategorized
  • Variations
  • WHO
  • World Patient Safety Day

Sign up and manage updates

  • Email
  • Atom

Follow us

  • MHRA on Twitter
  • MHRA Medicines Twitter
  • MHRA on LinkedIn
  • MHRA on Facebook

Other MHRA Blogs

MHRA Inspectorate

Useful links

  • All GOV.UK blogs
  • All GOV.UK blog posts
  • GOV.UK
  • All departments
  • Accessibility statement
  • Cookies
All content is available under the Open Government Licence v3.0, except where otherwise stated
© Crown copyright